⌘K

Home/Filings/4/0001171843-12-003089

4//SEC Filing

Capstone Therapeutics Corp. 4

Accession 0001171843-12-003089

$CAPSCIK 0000887151operating

View on SEC.gov Company Profile

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 1:23 PM ET

Size

5.0 KB

Accession

0001171843-12-003089

Insider Transaction Report

Form 4

Period: 2012-08-09

Capstone Therapeutics Corp.CAPS

HOLLIMAN JOHN M III

DirectorExecutive Chairman

Transactions

Award
Stock Option (Right to Buy)
2012-08-09+65,000→ 785,000 total
Exercise: $0.16From: 2012-08-09Exp: 2022-08-09→ Common Stock (65,000 underlying)

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Capstone Therapeutics Corp.

CIK 0000887151

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000887151

Filing Metadata

Form type: 4
Filed: Aug 9, 8:00 PM ET
Accepted: Aug 10, 1:23 PM ET
Size: 5.0 KB

View on SEC.gov